Mesothelin, shown to play a role in promoting cancer cell survival, proliferation, and invasion of cancer cell lines enabling cancer cells to thrive in an inflammatory milieu, is significantly overexpressed in CRC tissue compared to healthy colorectal tissue and is a candidate biomarker for targeted therapy [18, 32, 33]. This evidence concerns the gene MSLN and cancer.